{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:46:14Z","timestamp":1785491174662,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.neo.2019.11.003","type":"journal-article","created":{"date-parts":[[2019,12,29]],"date-time":"2019-12-29T23:10:18Z","timestamp":1577661018000},"page":"86-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Functional Cellular Anti-Tumor Mechanisms are Augmented by Genetic Proteoglycan Targeting"],"prefix":"10.1016","volume":"22","author":[{"given":"Purva","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"El Ghazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina I.","family":"Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.neo.2019.11.003_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.imlet.2004.05.003","article-title":"Interferon-gamma is an autocrine mediator for dendritic cell maturation","volume":"94","author":"Pan","year":"2004","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.neo.2019.11.003_b0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3121\/cmr.3.3.166","article-title":"Immunoregulation of dendritic cells","volume":"3","author":"Wallet","year":"2005","journal-title":"Clin Med Res"},{"issue":"25","key":"10.1016\/j.neo.2019.11.003_b0015","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1056\/NEJMra072739","article-title":"Cancer immunology","volume":"358","author":"Finn","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.neo.2019.11.003_b0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.neo.2019.11.003_b0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrclinonc.2014.111","article-title":"Therapeutic vaccines for cancer: an overview of clinical trials","volume":"11","author":"Melero","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.neo.2019.11.003_b0030","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1183\/09031936.06.00114205","article-title":"Characterisation of dendritic cell subsets in lung cancer micro-environments","volume":"28","author":"Bergeron","year":"2006","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.neo.2019.11.003_b0035","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/JTO.0b013e31821c421d","article-title":"Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7\u2013H3","volume":"6","author":"Schneider","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.neo.2019.11.003_b0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc3973","article-title":"Evolving synergistic combinations of targeted immunotherapies to combat cancer","volume":"15","author":"Melero","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.neo.2019.11.003_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.neo.2019.11.003_b0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res"},{"issue":"5","key":"10.1016\/j.neo.2019.11.003_b0055","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.4049\/jimmunol.1301286","article-title":"Lymphatic specific disruption in the fine structure of heparan sulfate inhibits dendritic cell traffic and functional T cell responses in the lymph node","volume":"192","author":"Yin","year":"2014","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.neo.2019.11.003_b0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neo.2016.04.004","article-title":"Glycan sulfation modulates dendritic cell biology and tumor growth","volume":"18","author":"El Ghazal","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2019.11.003_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2014.05.009","article-title":"Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice","volume":"408","author":"Abram","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.neo.2019.11.003_b0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coi.2014.11.001","article-title":"Reis e Sousa C: defining dendritic cells","volume":"32","author":"Schraml","year":"2015","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.neo.2019.11.003_b0075","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.RES.0000159708.71142.c8","article-title":"Syndecans: new kids on the signaling block","volume":"96","author":"Tkachenko","year":"2005","journal-title":"Circ Res"},{"issue":"86","key":"10.1016\/j.neo.2019.11.003_b0080","doi-asserted-by":"crossref","DOI":"10.3791\/50269-v","article-title":"Endotracheal intubation in mice via direct laryngoscopy using an otoscope","author":"Thomas","year":"2014","journal-title":"J Vis Exp"},{"issue":"4","key":"10.1016\/j.neo.2019.11.003_b0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"14","key":"10.1016\/j.neo.2019.11.003_b0090","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1016\/S0021-9258(18)83150-7","article-title":"Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase","volume":"264","author":"Bame","year":"1989","journal-title":"J Biol Chem"},{"issue":"48","key":"10.1016\/j.neo.2019.11.003_b0095","doi-asserted-by":"crossref","first-page":"33674","DOI":"10.1074\/jbc.M804288200","article-title":"Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling","volume":"283","author":"Lawrence","year":"2008","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.neo.2019.11.003_b0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/glycob\/cwh057","article-title":"Mapping critical biological motifs and biosynthetic pathways of heparan sulfate","volume":"14","author":"Lawrence","year":"2004","journal-title":"Glycobiology"},{"issue":"4","key":"10.1016\/j.neo.2019.11.003_b0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1008942828960","article-title":"Conditional gene targeting in macrophages and granulocytes using LysMcre mice","volume":"8","author":"Clausen","year":"1999","journal-title":"Transgenic Res"},{"issue":"4","key":"10.1016\/j.neo.2019.11.003_b0110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9440(10)61184-4","article-title":"Analysis of tumor vessel supply in Lewis lung carcinoma in mice by fluorescent microsphere distribution and imaging with micro- and flat-panel computed tomography","volume":"167","author":"Savai","year":"2005","journal-title":"Am J Pathol"},{"issue":"17","key":"10.1016\/j.neo.2019.11.003_b0115","doi-asserted-by":"crossref","first-page":"14952","DOI":"10.1074\/jbc.M110.206664","article-title":"Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C)","volume":"286","author":"Yin","year":"2011","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.neo.2019.11.003_b0120","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.188.11.2175","article-title":"Dendritic cell survival and maturation are regulated by different signaling pathways","volume":"188","author":"Rescigno","year":"1998","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.neo.2019.11.003_b0125","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.4049\/jimmunol.179.9.5778","article-title":"Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation","volume":"179","author":"Chung","year":"2007","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.neo.2019.11.003_b0130","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1038\/jid.2014.254","article-title":"DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth","volume":"134","author":"Chung","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.neo.2019.11.003_b0135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cmet.2014.09.016","article-title":"Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling","volume":"20","author":"Gordts","year":"2014","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.neo.2019.11.003_b0140","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/glycob\/cwu137","article-title":"Macrophage polarization alters the expression and sulfation pattern of glycosaminoglycans","volume":"25","author":"Martinez","year":"2015","journal-title":"Glycobiology"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558619303045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558619303045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:06:28Z","timestamp":1761483988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558619303045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1476558619303045"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2019.11.003","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Cellular Anti-Tumor Mechanisms are Augmented by Genetic Proteoglycan Targeting","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2019.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}